2009
DOI: 10.1016/s1098-3015(10)75381-x
|View full text |Cite
|
Sign up to set email alerts
|

Pcv16 Cost-Effectiveness Analysis of Thrombolysis With Recombinant Tissue Plasminogen Activator (Alteplase) for Acute Ischemic Stroke Under the Brazilian Public Health Care System Perspective

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles